sb 203580 has been researched along with alpha-synuclein in 4 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SH; Kim, EM; Kim, HS; Kim, S; Lee, S; Lee, SH; Min, K; Park, CH; Rah, JC; Seo, JH; Shin, JK; Suh, SW; Suh, YH | 1 |
| Clough, RL; Stefanis, L | 1 |
| Chen, J; Gui, C; Li, W; Mao, K; Ren, Y; Wu, X; Zhao, M; Zou, F | 1 |
| Chen, J; Gui, C; Li, H; Li, W; Mao, K; Ren, Y; Wu, X; Yu, H; Zou, F | 1 |
4 other study(ies) available for sb 203580 and alpha-synuclein
| Article | Year |
|---|---|
Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway.
Topics: alpha-Synuclein; Animals; Blotting, Western; Cell Line; Cell Survival; Cells, Cultured; Chromones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Humans; Imidazoles; Morpholines; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; RNA, Messenger; Signal Transduction; Synucleins; Time Factors; Tumor Cells, Cultured | 2002 |
A novel pathway for transcriptional regulation of alpha-synuclein.
Topics: alpha-Synuclein; Animals; Anthracenes; Blotting, Western; Butadienes; Chromones; Enzyme Inhibitors; Fibroblast Growth Factor 2; Gene Expression Regulation; Humans; Imidazoles; Introns; JNK Mitogen-Activated Protein Kinases; Models, Biological; Morpholines; Nerve Growth Factor; Nitriles; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2007 |
Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apoptosis; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Enzyme Activation; Humans; Imidazoles; Mice, Transgenic; Mitochondria; Mitophagy; Mutant Proteins; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Phosphoserine; Protein Kinases; Pyridines; Synapses; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2018 |
p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apoptosis; Cell Line, Tumor; Dynamins; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mitochondria; Mitochondrial Dynamics; Mutation; Neurons; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Pyridines; Reactive Oxygen Species; Serine | 2020 |